Incident tuberculosis disease in patients receiving biologic therapies in the Western Cape, South Africa from 2007 to 2018

BACKGROUND: South Africa has one of the highest tuberculosis incidence rates. Biologic disease-modifying anti-rheumatic drugs are associated with an increased risk of tuberculosis. The objective of this study was to describe the tuberculosis disease incidence rate among public sector patients receiv...

Descripción completa

Detalles Bibliográficos
Autores principales: du Toit, Tessa, Esterhuizen, Tonya M., Tiffin, Nicki, Abulfathi, Ahmed A., Reuter, Helmuth, Decloedt, Eric H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706240/
https://www.ncbi.nlm.nih.gov/pubmed/33256634
http://dx.doi.org/10.1186/s12879-020-05624-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706240/
https://www.ncbi.nlm.nih.gov/pubmed/33256634
http://dx.doi.org/10.1186/s12879-020-05624-0

Ejemplares similares